Cargando…

Morphological and functional retinal changes in neovascular age-related macular degeneration treated with intravitreal bevacizumab

PURPOSE: This study was conducted to determine the morphological and functional retinal changes in patients with neovascular age-related macular degeneration (nAMD) treated with intravitreal bevacizumab 1.25 mg. METHODS: This was a prospective, nonrandomized, interventional study. Eighteen eyes of 1...

Descripción completa

Detalles Bibliográficos
Autores principales:	Damkondwar, Deepali R, Srinivasan, Ramyaa, Raman, Rajiv, Kulothungan, Vaitheeswaran, Sharma, Tarun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9940573/ https://www.ncbi.nlm.nih.gov/pubmed/36453348 http://dx.doi.org/10.4103/ijo.IJO_1184_22

Ejemplares similares

Assessing Framingham cardiovascular risk scores in subjects with diabetes and their correlation with diabetic retinopathy
por: Damkondwar, Deepali R, et al.
Publicado: (2012)

Microperimetry biofeedback training in a patient with bilateral myopic macular degeneration with central scotoma
por: Raman, Rajiv, et al.
Publicado: (2015)

Association of obesity and age-related macular degeneration in Indian population
por: Jaisankar, Durgasri, et al.
Publicado: (2018)

Association of systemic and ocular risk factors with neurosensory retinal detachment in diabetic macular edema: a case–control study
por: Gupta, Aditi, et al.
Publicado: (2014)

Response to comment on: Association of obesity and age-related macular degeneration in Indian population
por: Jaisankar, Durgasri, et al.
Publicado: (2019)

Communications between intraretinal and subretinal space on optical coherence tomography of neurosensory retinal detachment in diabetic macular edema
por: Gupta, Aditi, et al.
Publicado: (2013)

Intravitreal Bevacizumab versus Combined Bevacizumab and Triamcinolone Acetonide for Neovascular Age-Related Macular Degeneration
por: Riazi-Esfahani, Mohammad, et al.
Publicado: (2008)

Intravitreal Bevacizumab for Choroidal Neovascularization Secondary to Non-Age-Related Macular Degeneration
por: Salehipour, Masoud, et al.
Publicado: (2010)

Is monthly retreatment with intravitreal bevacizumab (Avastin(®)) necessary in neovascular age-related macular degeneration?
por: Ghazi, Nicola G, et al.
Publicado: (2010)

Predictors of Visual Response to Intravitreal Bevacizumab for Treatment of Neovascular Age-Related Macular Degeneration
por: Fang, Kai, et al.
Publicado: (2013)

The Role of Epiretinal Membrane on Treatment of Neovascular Age-Related Macular Degeneration with Intravitreal Bevacizumab
por: Alkin, Zeynep, et al.
Publicado: (2013)

Macular Hole following Intravitreal Bevacizumab Injection in Choroidal Neovascularization Caused by Age-Related Macular Degeneration
por: Moisseiev, Elad, et al.
Publicado: (2010)

Lamellar macular hole formation following intravitreal bevacizumab injection for choroidal neovascularization by age-related macular degeneration
por: Torabi, Hamidreza, et al.
Publicado: (2018)

The effect of intravitreal bevacizumab (Avastin(®)) on ocular pulse amplitude in neovascular age-related macular degeneration
por: Rechtman, Ehud, et al.
Publicado: (2011)

Intravitreal Aflibercept Outcomes in Patients with Persistent Macular Exudate Previously Treated with Bevacizumab and/or Ranibizumab for Neovascular Age-Related Macular Degeneration
por: Griffin, David R., et al.
Publicado: (2014)

Relationship between triglyceride glucose index, retinopathy and nephropathy in Type 2 diabetes
por: Srinivasan, Sangeetha, et al.
Publicado: (2020)

Single-session photodynamic therapy combined with intravitreal bevacizumab and triamcinolone for neovascular age-related macular degeneration
por: Ahmadieh, Hamid, et al.
Publicado: (2007)

Comparative role of intravitreal ranibizumab versus bevacizumab in choroidal neovascular membrane in age-related macular degeneration
por: Biswas, Partha, et al.
Publicado: (2011)

Intravitreal Expansile Gas and Bevacizumab Injection for Submacular Hemorrhage Due to Neovascular Age-related Macular Degeneration
por: Nourinia, Ramin, et al.
Publicado: (2010)

Multifocal Electroretinogram Findings after Intravitreal Bevacizumab Injection in Choroidal Neovascularization of Age-Related Macular Degeneration
por: Park, Joo Youn, et al.
Publicado: (2011)

Two Different Doses of Intravitreal Bevacizumab for Treatment of Choroidal Neovascularization Associated with Age-related Macular Degeneration
por: Modarreszadeh, Mehdi, et al.
Publicado: (2008)

Safety and clinical effectiveness of intravitreal administration of bevacizumab (Lumiere(®)) in patients with neovascular age-related macular degeneration
por: Benisek, Daniel A., et al.
Publicado: (2020)

Evaluation of Aqueous Flare Intensity in Eyes Undergoing Intravitreal Bevacizumab Therapy to Treat Neovascular Age-Related Macular Degeneration
por: Dolar-Szczasny, Joanna, et al.
Publicado: (2021)

Intravitreal Bevacizumab for Choroidal Neovascular Membrane in Macular Telangiectasia Type 2
por: Gonzalez Martinez, Orlando G, et al.
Publicado: (2023)

Combined intravitreal bevacizumab and photodynamic therapy with vertiporfin for management of choroidal neovascularization secondary to age-related macular degeneration
por: Kabeel, Mamdouh M, et al.
Publicado: (2008)

Mortality in patients treated with intravitreal bevacizumab for age-related macular degeneration
por: Hanhart, Joel, et al.
Publicado: (2017)

Influence of unilateral intravitreal bevacizumab injection on the incidence of symptomatic choroidal neovascularization in the fellow eye in patients with neovascular age-related macular degeneration (Review)
por: Branisteanu, Daniel Constantin, et al.
Publicado: (2020)

Intravitreal bevacizumab has initial clinical benefit lasting eight weeks in eyes with neovascular age-related macular degeneration
por: Conrad, P William, et al.
Publicado: (2008)

Skin rash associated with intravitreal bevacizumab in a patient with macular choroidal neovascularization
por: Ladas, Ioannis D, et al.
Publicado: (2009)

Diagonal ear lobe crease in diabetic south Indian population: Is it associated with Diabetic Retinopathy?. Sankara Nethralaya Diabetic Retinopathy Epidemiology And Molecular-genetics Study (SN-DREAMS, Report no. 3)
por: Raman, Rajiv, et al.
Publicado: (2009)

Subretinal Neovascular Membrane in Wet Age-Related Macular Degeneration Managed With Intravitreal Ranibizumab
por: Sharma, Tanishq S, et al.
Publicado: (2021)

Retinal pigment epithelial tears after intravitreal bevacizumab injection for exudative age-related macular degeneration
por: Shaikh, Saad, et al.
Publicado: (2007)

Retinal pigment epithelial tear after intravitreal bevacizumab injection for exudative age-related macular degeneration
por: Singh, Sunil Kumar, et al.
Publicado: (2014)

Choroideremia associated with choroidal neovascularization treated with intravitreal bevacizumab
por: Palejwala, Neal V, et al.
Publicado: (2014)

Triple therapy for neovascular age-related macular degeneration using single-session photodynamic therapy combined with intravitreal bevacizumab and triamcinolone
por: Yip, P P, et al.
Publicado: (2009)

Photodynamic Therapy and Intravitreal Bevacizumab with Versus without Triamcinolone for Neovascular Age-related Macular Degeneration; a Randomized Clinical Trial
por: Piri, Niloofar, et al.
Publicado: (2014)

Intravitreal bevacizumab plus propranolol for neovascular age-related macular degeneration (the BEVALOL study): a phase I clinical trial
por: Silva Tavares Neto, José Edísio da, et al.
Publicado: (2023)

Macular Hole Formation Following Intravitreal Aflibercept for Neovascular Age-Related Macular Degeneration
por: Ali Said, Yasmin, et al.
Publicado: (2022)

Intravitreal Faricimab for Aflibercept-Resistant Neovascular Age-Related Macular Degeneration
por: Rush, Ryan B, et al.
Publicado: (2022)

Visual and anatomical outcomes associated with treat-and-extend administration of intravitreal aflibercept for neovascular age-related macular degeneration
por: Soliman, Mohamed Kamel, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_lbq3ptm9d4madnnobtu78dnh1k